Cargando…

A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea

BACKGROUND: The use of intravenous contrast media (CM) has increased for the diagnosis of several diseases. The newly developed low osmolar nonionic contrast agents cause significantly decreased adverse reactions than the higher osmolar ones. However, adverse reactions may still occur, ranging in se...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Kyung Eun, Chung, Jimin, Park, Byung Cheol, Jee, Keum Nahn, Jee, Young Koo, Kim, Myung Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283846/
https://www.ncbi.nlm.nih.gov/pubmed/22363151
http://dx.doi.org/10.5021/ad.2012.24.1.22
_version_ 1782224266786242560
author Jung, Kyung Eun
Chung, Jimin
Park, Byung Cheol
Jee, Keum Nahn
Jee, Young Koo
Kim, Myung Hwa
author_facet Jung, Kyung Eun
Chung, Jimin
Park, Byung Cheol
Jee, Keum Nahn
Jee, Young Koo
Kim, Myung Hwa
author_sort Jung, Kyung Eun
collection PubMed
description BACKGROUND: The use of intravenous contrast media (CM) has increased for the diagnosis of several diseases. The newly developed low osmolar nonionic contrast agents cause significantly decreased adverse reactions than the higher osmolar ones. However, adverse reactions may still occur, ranging in severity from minor side effects to severe complications. However, there have been few reports about cutaneous adverse reactions (CARs) to nonionic monomer CM. OBJECTIVE: The purpose of this study was to evaluate clinical features of CAR to intravenous nonionic monomer CM. METHODS: A total 47,338 examinees underwent intravenous iodinated contrast-enhanced computed tomography scan using nonionic monomer CM. Among the adverse reactions to the CM, we divided them into cutaneous or noncutaneous and immediate (<1 hr) or late (≥1 hr) adverse reactions. RESULTS: Adverse reactions were noted in 62 cases out of the total 47,338 cases; 50 cases (80.7%) were categorized CARs. Among them, there were 24 male and 26 female patients. There was no significant difference between the sexes, and CARs occurred in all age groups. The highest occurrence was in the age range of 50~59 years. CARs included urticaria (78%), angioedema (10%), maculopapular rash (8%), erythema (2%), and pruritus without rash (2%). Immediate reactions were 92% (46 cases), while late reactions were 8% (4 cases). CONCLUSION: CARs to nonionic monomer CM accounted for most of the adverse reactions (80.7%) and urticaria was the most common.
format Online
Article
Text
id pubmed-3283846
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-32838462012-02-23 A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea Jung, Kyung Eun Chung, Jimin Park, Byung Cheol Jee, Keum Nahn Jee, Young Koo Kim, Myung Hwa Ann Dermatol Original Article BACKGROUND: The use of intravenous contrast media (CM) has increased for the diagnosis of several diseases. The newly developed low osmolar nonionic contrast agents cause significantly decreased adverse reactions than the higher osmolar ones. However, adverse reactions may still occur, ranging in severity from minor side effects to severe complications. However, there have been few reports about cutaneous adverse reactions (CARs) to nonionic monomer CM. OBJECTIVE: The purpose of this study was to evaluate clinical features of CAR to intravenous nonionic monomer CM. METHODS: A total 47,338 examinees underwent intravenous iodinated contrast-enhanced computed tomography scan using nonionic monomer CM. Among the adverse reactions to the CM, we divided them into cutaneous or noncutaneous and immediate (<1 hr) or late (≥1 hr) adverse reactions. RESULTS: Adverse reactions were noted in 62 cases out of the total 47,338 cases; 50 cases (80.7%) were categorized CARs. Among them, there were 24 male and 26 female patients. There was no significant difference between the sexes, and CARs occurred in all age groups. The highest occurrence was in the age range of 50~59 years. CARs included urticaria (78%), angioedema (10%), maculopapular rash (8%), erythema (2%), and pruritus without rash (2%). Immediate reactions were 92% (46 cases), while late reactions were 8% (4 cases). CONCLUSION: CARs to nonionic monomer CM accounted for most of the adverse reactions (80.7%) and urticaria was the most common. Korean Dermatological Association; The Korean Society for Investigative Dermatology 2012-02 2012-02-02 /pmc/articles/PMC3283846/ /pubmed/22363151 http://dx.doi.org/10.5021/ad.2012.24.1.22 Text en Copyright © 2012 Korean Dermatological Association; The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jung, Kyung Eun
Chung, Jimin
Park, Byung Cheol
Jee, Keum Nahn
Jee, Young Koo
Kim, Myung Hwa
A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea
title A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea
title_full A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea
title_fullStr A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea
title_full_unstemmed A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea
title_short A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea
title_sort clinical study of cutaneous adverse reactions to nonionic contrast media in korea
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283846/
https://www.ncbi.nlm.nih.gov/pubmed/22363151
http://dx.doi.org/10.5021/ad.2012.24.1.22
work_keys_str_mv AT jungkyungeun aclinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea
AT chungjimin aclinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea
AT parkbyungcheol aclinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea
AT jeekeumnahn aclinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea
AT jeeyoungkoo aclinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea
AT kimmyunghwa aclinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea
AT jungkyungeun clinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea
AT chungjimin clinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea
AT parkbyungcheol clinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea
AT jeekeumnahn clinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea
AT jeeyoungkoo clinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea
AT kimmyunghwa clinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea